Spanios

We harness the powerful capabilities of Patient Derived Tumoroids (PDTs) to accelerate the drug development process for solid tumor cancers. Our platform uniquely creates stable tumor models that are biobanked for rapid deployment and enables reproducible studies. We maintain an intact and functional tumor microenvironment (TME) for therapeutic discoverers and developers whose studies require robust and faithful preclinical research models. Our unique 3D tumor models enable the recapitulation of patient-specific tumor-immune interactions to fast-track the search for novel cures and bring hope to millions of patients. Tumoroids are the perfectly optimized human tool for performing: biomarker discovery drug selection & ratios for more informed treatment decisions assessment of combination therapies drug rescue & repurposing search for predictive signatures of drug failure, toxicity and response derisking clinical trials testing within the platform to facilitate precision cancer immunotherapy